|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$120M
|
+$13M
|
+2,357,210
|
+23%
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$71.6M
|
–
|
–
|
–
|
|
|
3
|
|
$39.7M
|
+$2.71M
|
+489,260
|
+13%
|
|
|
4
|
Carlyle Group
Washington,
District of Columbia
|
$33.5M
|
–
|
–
|
–
|
|
|
5
|
|
$31.8M
|
-$45.7K
|
-8,255
|
-0.2%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$26.7M
|
+$47.7K
|
+8,624
|
+0.3%
|
|
|
7
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$24.2M
|
+$31.5K
|
+5,688
|
+0.2%
|
|
|
8
|
Millennium Management
New York
|
$21.6M
|
+$9.56M
|
+1,727,134
|
+330%
|
|
|
9
|
683 Capital Management
New York
|
$20.2M
|
+$3.65M
|
+660,000
|
+46%
|
|
|
10
|
NEA Management Company
Timonium,
Maryland
|
$18.8M
|
–
|
–
|
–
|
|
|
11
|
Wasatch Advisors
Salt Lake City,
Utah
|
$14M
|
-$1.33M
|
-239,732
|
-14%
|
|
|
12
|
Catalys Pacific
Tokyo,
Japan
|
$11.2M
|
–
|
–
|
–
|
|
|
13
|
Geode Capital Management
Boston,
Massachusetts
|
$10.3M
|
+$296K
|
+53,504
|
+5%
|
|
|
14
|
Avidity Partners Management
Dallas,
Texas
|
$10.2M
|
+$1.46M
|
+264,500
|
+33%
|
|
|
15
|
GW&K Investment Management
Boston,
Massachusetts
|
$10.1M
|
-$309K
|
-55,836
|
-5%
|
|
|
16
|
Propel Bio Management
Los Angeles,
California
|
$8.85M
|
-$1.17M
|
-212,000
|
-19%
|
|
|
17
|
State Street
Boston,
Massachusetts
|
$8.15M
|
-$287K
|
-51,930
|
-6%
|
|
|
18
|
Catalio Capital Management
New York
|
$6.45M
|
+$3.72M
|
+672,290
|
New
|
|
|
19
|
Moore Capital Management
New York
|
$5.75M
|
+$3.32M
|
+600,000
|
New
|
|
|
20
|
Simplify Asset Management
Las Vegas,
Nevada
|
$5.01M
|
-$885K
|
-160,000
|
-23%
|
|
|
21
|
|
$4.96M
|
-$75.3K
|
-13,612
|
-3%
|
|
|
22
|
StepStone Group
La Jolla,
California
|
$4.05M
|
–
|
–
|
–
|
|
|
23
|
UBS Group
Zurich,
Switzerland
|
$4.02M
|
-$1.59M
|
-288,105
|
-41%
|
|
|
24
|
Charles Schwab
San Francisco,
California
|
$3.45M
|
+$67.1K
|
+12,125
|
+3%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$3.45M
|
-$151K
|
-27,299
|
-7%
|
|
